Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines--a phase II multipractice study.

BMC cancer

Volumn 12, Issue , 2012, Pages

  John, Matthias ^a   Hinke, Axel ^b   Stauch, Martina ^b   Wolf, Heiner ^b   Mohr, Benno ^b   Hindenburg, Hans Joachim ^b   Papke, Jens ^b   Schlosser, Joachim ^b   FAKT Study Group, ^b  

^a Practice for Gynecology   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PACLITAXEL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER GRADING; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PACLITAXEL; PROGNOSIS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84860539754     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-165     Document Type: Article

References (0)